Though IFN-γ secretion was higher against CLL targets than control targets in 7 of 9 experiments, lytic killing of CLL targets was much higher than that of control targets in all 11 experiments. The gene discussed is IFNG; the disease is B-cell chronic lymphocytic leukemia.